Irinotecan and Panitumumab as 3rd Line Treatment for mCRC Without KRAS Mutations

Clinical trial NCT00792363 · COMPLETED

Trial details

NCT number: NCT00792363
Sponsor: Vejle Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2008-11-01
Primary completion: 2010-12-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.